Ami Organics gets 79 percent of the revenue comes from pharma space wherein it manufactures intermediates for APIs and NCE (New Chemical Entities). Rest of the revenue comes from chemicals segment. While company’s foray into the lithium-ion batteries and the semiconductor industry value chain is a key watch, ramp-up in CDMO (Contract Development and Manufacturing Organization) contracts is expected to be the key earnings catalyst.
first published: Jan 8, 2025 08:00 am
A collection of the most-viewed Moneycontrol videos.
Live: Nifty fails to defend 25,100, breaks 4-day surge | Closing Bell
Live: Can bulls continue to defend Nifty's 25,100 zone? | Opening Bell
Live: Nifty holds gain for 4th day, above 25,100 on weekly expiry day | Closing bell
Zoho CEO Mani Vembu On Why India Needs Arattai, Growth Surge And Integrating Businesses | Exclusive
